| MiR-372 seemed to function as a tumour suppressor in renal cell carcinoma progression by inhibiting the IGF2BP1 expression. | kidney, |
| MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting ATAD2 in renal cell carcinoma | kidney, |
| A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. | testicular, |
| miRNA-372 and miRNA-373 have roles as oncogenes in testicular germ cell tumors | testicular, |
| miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. | gastric, |
| MicroRNA-372 is associated with poor prognosis in colorectal cancer. | colorectal, |
| microRNA-372 maintains oncogene characteristics by targeting TNFAIP1 and affects NFkappaB signaling in human gastric carcinoma cells. | gastric, |
| miR-372 may act as an oncogenic miRNA in gliomas and could represent a potential regulator of aggressive development and a candidate prognostic marker for this malignancy. | glioma, |
| miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis. | liver, |